163 related articles for article (PubMed ID: 27402288)
41. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
42. Dietary N-Glycans from Bovine Lactoferrin and TLR Modulation.
Figueroa-Lozano S; Valk-Weeber RL; van Leeuwen SS; Dijkhuizen L; de Vos P
Mol Nutr Food Res; 2018 Jan; 62(2):. PubMed ID: 28971586
[TBL] [Abstract][Full Text] [Related]
43. IL-21 enhances the activity of the TLR-MyD88-STAT3 pathway but not the classical TLR-MyD88-NF-κB pathway in human B cells to boost antibody production.
Liu BS; Stoop JN; Huizinga TW; Toes RE
J Immunol; 2013 Oct; 191(8):4086-94. PubMed ID: 24043893
[TBL] [Abstract][Full Text] [Related]
44. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
Abdulkhalek S; Szewczuk MR
Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
[TBL] [Abstract][Full Text] [Related]
45. Tetradecanoyl phorbol acetate induces expression of Toll-like receptor 2 in U937 cells: involvement of PKC, ERK, and NF-kappaB.
Jang BC; Jung TY; Paik JH; Kwon YK; Shin SW; Kim SP; Ha JS; Suh MH; Suh SI
Biochem Biophys Res Commun; 2005 Mar; 328(1):70-7. PubMed ID: 15670752
[TBL] [Abstract][Full Text] [Related]
46. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
Rajalakshmy AR; Malathi J; Madhavan HN
PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
[TBL] [Abstract][Full Text] [Related]
47. Toll-like receptors and their role in hematologic malignancies.
Wolska A; Lech-Maranda E; Robak T
Curr Mol Med; 2009 Apr; 9(3):324-35. PubMed ID: 19355914
[TBL] [Abstract][Full Text] [Related]
48. B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies.
Koehrer S; Burger JA
Clin Adv Hematol Oncol; 2016 Jan; 14(1):55-65. PubMed ID: 27057669
[TBL] [Abstract][Full Text] [Related]
49. The Drosophila Toll signaling pathway.
Valanne S; Wang JH; Rämet M
J Immunol; 2011 Jan; 186(2):649-56. PubMed ID: 21209287
[TBL] [Abstract][Full Text] [Related]
50. The structural network of inflammation and cancer: merits and challenges.
Guven Maiorov E; Keskin O; Gursoy A; Nussinov R
Semin Cancer Biol; 2013 Aug; 23(4):243-51. PubMed ID: 23712403
[TBL] [Abstract][Full Text] [Related]
51. Activin suppresses LPS-induced Toll-like receptor, cytokine and inducible nitric oxide synthase expression in normal human melanocytes by inhibiting NF-κB and MAPK pathway activation.
Kim YI; Park SW; Kang IJ; Shin MK; Lee MH
Int J Mol Med; 2015 Oct; 36(4):1165-72. PubMed ID: 26259928
[TBL] [Abstract][Full Text] [Related]
52. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
53. NF-κB: where did it come from and why?
Gilmore TD; Wolenski FS
Immunol Rev; 2012 Mar; 246(1):14-35. PubMed ID: 22435545
[TBL] [Abstract][Full Text] [Related]
54. Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines.
Meloni M; Sana I; Mantione ME; Riba M; Muzio M
FEBS Open Bio; 2023 Dec; 13(12):2367-2374. PubMed ID: 37881888
[TBL] [Abstract][Full Text] [Related]
55. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
56. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
[TBL] [Abstract][Full Text] [Related]
57. Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.
Wang Q; Dziarski R; Kirschning CJ; Muzio M; Gupta D
Infect Immun; 2001 Apr; 69(4):2270-6. PubMed ID: 11254583
[TBL] [Abstract][Full Text] [Related]
58. The role of toll-like receptors in chronic B-cell malignancies.
Muzio M; Bertilaccio MT; Simonetti G; Frenquelli M; Caligaris-Cappio F
Leuk Lymphoma; 2009 Oct; 50(10):1573-80. PubMed ID: 19672768
[TBL] [Abstract][Full Text] [Related]
59. Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells.
Grandjenette C; Kennel A; Faure GC; Béné MC; Feugier P
Haematologica; 2007 Sep; 92(9):1279-81. PubMed ID: 17768129
[TBL] [Abstract][Full Text] [Related]
60. Characterization of a Toll-like receptor (TLR) signaling pathway in Biomphalaria glabrata and its potential regulation by NF-kappaB.
Humphries JE; Deneckere LE
Dev Comp Immunol; 2018 Sep; 86():118-129. PubMed ID: 29746981
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
